BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21440326)

  • 1. New insights into stability of recombinant adenovirus vector genomes in mammalian cells.
    Rauschhuber C; Noske N; Ehrhardt A
    Eur J Cell Biol; 2012 Jan; 91(1):2-9. PubMed ID: 21440326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver.
    Jager L; Ehrhardt A
    Hum Gene Ther; 2009 Aug; 20(8):883-96. PubMed ID: 19364285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-capacity 'gutless' adenoviral vectors.
    Kochanek S; Schiedner G; Volpers C
    Curr Opin Mol Ther; 2001 Oct; 3(5):454-63. PubMed ID: 11699889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid protocol for construction and production of high-capacity adenoviral vectors.
    Jager L; Hausl MA; Rauschhuber C; Wolf NM; Kay MA; Ehrhardt A
    Nat Protoc; 2009; 4(4):547-64. PubMed ID: 19373227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging adenoviral vectors for stable correction of genetic disorders.
    Jager L; Ehrhardt A
    Curr Gene Ther; 2007 Aug; 7(4):272-83. PubMed ID: 17969560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
    Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
    Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA.
    Stephen SL; Sivanandam VG; Kochanek S
    J Gene Med; 2008 Nov; 10(11):1176-89. PubMed ID: 18773501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
    Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
    Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo.
    Yant SR; Ehrhardt A; Mikkelsen JG; Meuse L; Pham T; Kay MA
    Nat Biotechnol; 2002 Oct; 20(10):999-1005. PubMed ID: 12244327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust functional gene validation by adenoviral vectors: one-step Escherichia coli-derived recombinant adenoviral genome construction.
    Mullan B; Dugué C; Moutard V; Raoux D; Tremp G; Denèfle P; Perricaudet M; Robert JJ
    Gene Ther; 2004 Nov; 11(21):1599-605. PubMed ID: 15334112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
    Bilbao R; Reay DP; Wu E; Zheng H; Biermann V; Kochanek S; Clemens PR
    Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV serotype 2 vectors preferentially integrate into active genes in mice.
    Nakai H; Montini E; Fuess S; Storm TA; Grompe M; Kay MA
    Nat Genet; 2003 Jul; 34(3):297-302. PubMed ID: 12778174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
    Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
    Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors.
    Kreppel F; Kochanek S
    J Virol; 2004 Jan; 78(1):9-22. PubMed ID: 14671083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses.
    Mück-Häusl M; Solanki M; Zhang W; Ruzsics Z; Ehrhardt A
    Nucleic Acids Res; 2015 Apr; 43(8):e50. PubMed ID: 25609697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
    Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
    Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
    Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
    Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors.
    Gonçalves MA; van der Velde I; Knaän-Shanzer S; Valerio D; de Vries AA
    Virology; 2004 Apr; 321(2):287-96. PubMed ID: 15051388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient foamy virus vector production by adenovirus vectors.
    Russell RA; Vassaux G; Martin-Duque P; McClure MO
    Gene Ther; 2004 Feb; 11(3):310-6. PubMed ID: 14737091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
    Kügler S; Kilic E; Bähr M
    Gene Ther; 2003 Feb; 10(4):337-47. PubMed ID: 12595892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.